Your browser doesn't support javascript.
loading
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.
Ghesquières, Hervé; Larrabee, Beth R; Casasnovas, Olivier; Maurer, Matthew J; McKay, James D; Ansell, Stephen M; Montgomery, Dorothy; Asmann, Yan W; Farrell, Katrina; Verney, Aurélie; Slager, Susan L; Allmer, Cristine; Perrot, Aurore; Delarue, Richard; Habermann, Thomas M; Dupuis, Jehan; Link, Brian K; Canioni, Danielle; Dogan, Ahmet; Cozen, Wendy; Jarrett, Ruth F; Cerhan, James R; Salles, Gilles.
Afiliación
  • Ghesquières H; Department of Haematology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Larrabee BR; Centre de Recherche en Cancérologie de Lyon - INSERM U 1052/CNRS UMR 5286/Centre Léon Bérard, Lyon, France.
  • Casasnovas O; Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Maurer MJ; Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • McKay JD; Department of Haematology, Hôpital Le Bocage-CHU Dijon, Dijon, France.
  • Ansell SM; Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Montgomery D; International Agency for Research on Cancer (IARC), Lyon, France.
  • Asmann YW; Division of Haematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Farrell K; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Verney A; Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Slager SL; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Allmer C; Centre de Recherche en Cancérologie de Lyon - INSERM U 1052/CNRS UMR 5286/Centre Léon Bérard, Lyon, France.
  • Perrot A; Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Delarue R; Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Habermann TM; Department of Haematology, CHU Nancy-Brabois, Vandoeuvre, France.
  • Dupuis J; Department of Haematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker, Paris, France.
  • Link BK; Division of Haematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
  • Canioni D; Lymphoid Malignancies Unit, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil, France.
  • Dogan A; University of Iowa, Holden Comprehensive Cancer Center, Iowa City, IA, USA.
  • Cozen W; Department of Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker, Paris, France.
  • Jarrett RF; Department of Laboratory Medicine and Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Cerhan JR; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Salles G; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Br J Haematol ; 180(2): 286-290, 2018 01.
Article en En | MEDLINE | ID: mdl-27716907
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 8 / Enfermedad de Hodgkin / Genes myc / Predisposición Genética a la Enfermedad / Sitios Genéticos / ARN Largo no Codificante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosomas Humanos Par 8 / Enfermedad de Hodgkin / Genes myc / Predisposición Genética a la Enfermedad / Sitios Genéticos / ARN Largo no Codificante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido